Why the study?
Unmet needs remain for right ventricular outflow reconstruction to resolve pulmonary regurgitation after corrective surgery for congenital heart diseases, prompting review of the evolution of handmade ePTFE valves.
Do ePTFE handmade valves provide reliable clinical outcomes compared to allograft or xenograft options for pulmonary valve replacement in congenital heart disease?
Comparison
ePTFE-based valves vs allograft or xenograft options
Design
Systematic literature review
Key result
Expanded polytetrafluoroethylene (ePTFE) handmade valves for pulmonary valve replacement demonstrated 90.2% freedom from reintervention at 5 years and 96.7% survival at 3 years.
Authors
Loading...
Indicates potential durability of ePTFE valves; leaves open translation to clinical pulmonary valve replacement.
Do ePTFE handmade valves provide reliable clinical outcomes compared to allograft or xenograft options for pulmonary valve replacement in congenital heart disease?
Handmade ePTFE valves demonstrate non-inferior clinical outcomes compared to allografts or xenografts for pulmonary valve replacement, with excellent mid-term survival and freedom from reintervention.
Chang et al. (2020) conducted a review in Pulmonary regurgitation after corrective surgery for congenital heart diseases. Expanded polytetrafluoroethylene (ePTFE) handmade valves vs. Allograft or xenograft options was evaluated on Freedom from reintervention or surgery. Expanded polytetrafluoroethylene (ePTFE) handmade valves for pulmonary valve replacement demonstrated 90.2% freedom from reintervention at 5 years and 96.7% survival at 3 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: